Request Proposal

Meet Tatiana Dumpis, Medical Director at Confidence Pharmaceutical Research

1 min read

Meet Tatiana Dumpis, Medical Director at Confidence Pharmaceutical Research

Meet Tatiana Dumpis, Medical Director – and valuable member of the Confidence Pharmaceutical Research team. Dr. Dumpis’ impressive background in medicine, spanning clinical research, oncology, and academia, brings a wealth of expertise and a unique perspective to our organization.

With an MD from Pavlov State Medical University, specialty certifications in anesthesiology, intensive care, and medical oncology, and extensive international training, Dr. Dumpis is a seasoned professional dedicated to ensuring the safety and well-being of patients throughout the clinical trial process. Her extensive clinical experience in diagnosing and treating solid tumors and hematological malignancies, combined with over 8 years of experience in medical monitoring of I-IV phase clinical trials, makes her a highly sought-after expert in her field.

Dr. Dumpis plays a crucial role in upholding the highest standards of safety, data integrity, and ethical conduct across all our clinical trials. Her leadership ensures that our trials are conducted with the utmost care and precision, increasing the likelihood of successful outcomes and regulatory approvals.

For inquiries or further information, please email us at [email protected] or give us a call at +1 (650) 407-1986.

Related News

Explore recent updates, announcements, and insights.

The Relationship between CROs and Pharmaceutical Companies

The following formula about clinical trials won’t appear in any textbook, but it is very real for small- to

Current Trends in Clinical Research

Pharmaceutical research and development contributes significantly to today’s rising health care costs. Clinical research, a critical component of pharma

Why These Are the Top Countries for Conducting Clinical Trials

Clinical trials are currently being held on every continent except Antarctica. However, emerging countries have long been rising to